The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 92-97

  Yalcinkaya, Yasemin ^a   Pehlivan, Ozlem ^a   Omma, Ahmet ^a   Alpay, Nilufer ^a   Erer, Burak ^a   Kamali, Sevil ^a   Ocal, Lale ^a   Inanc, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Capillaroscopy; Peripheral vascular involvement; Systemic sclerosis; Telangiectasia score

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; IMMUNOSUPPRESSIVE AGENT; PROTON PUMP INHIBITOR; STEROID;

ADULT; AGED; ARTICLE; CAPILLAROSCOPY; CAPILLARY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FINGER ULCER; HUMAN; LEROY AND MEDSGER CRITERIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROANGIOPATHY EVOLUTION SCORE; NAILFOLD VIDEO CAPILLAROSCOPY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEX DIFFERENCE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VALENTINI ACTIVITY SCORE; ANGIOSCOPY; COMPLICATION; CROSS-SECTIONAL STUDY; FINGER; ISCHEMIA; MIDDLE AGED; NAIL; PATHOLOGY; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN ULCER; TELANGIECTASIS; VASCULARIZATION; VIDEORECORDING;

ADULT; CAPILLARIES; CROSS-SECTIONAL STUDIES; FEMALE; FINGERS; HUMANS; ISCHEMIA; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SKIN ULCER; TELANGIECTASIS; VIDEO RECORDING;

EID: 84946224824     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. VARGA J, ABRAHAM D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-67.
2. WIGLEY FM: Vascular disease in scleroderma. Clin Rev Allerg Immunol 2009; 36: 150-75.
3. DISTLER JH, GAY S, DISTLER O: Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology (Oxford) 2006; 45: 26-7.
4. WALKER UA, TYNDALL A, CZIRJáK L et al.: Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
5. CUTOLO M, SULLI A, SMITH V: Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010; 6: 578-87.
6. INGEGNOLI F, BORACCHI P, GUALTIEROTTI R et al.: Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum 2008; 58: 2174-82.
7. PAVLOV-DOLIJANOVIC S, DAMJANOV NS, STOJANOVIC RM, VUJASINOVIC STUPAR NZ, STANISAVLJEVIC DM: Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int 2012; 32: 3039-45.
8. HERRICK AL, CUTOLO M: Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 2010; 62: 2595-604.
9. CUTOLO M, SULLI A, PIZZORNI C, ACCARDO S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-60.
10. SULLI A, SECCHI ME, PIZZORNI C, CUTOLO M: Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-87.
11. SMITH V, CARMEN P, FILIP De K et al.: Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study. Ann Rheum Dis 2010; 69: 1092-6.
12. SEBASTIANI M, MANFREDI A, VUKATANA G et al.: Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012; 71: 67-70.
13. SMITH V, DECUMAN S, SULLI A et al.: Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 2012; 71: 1636-9.
14. GUIDUCCI S, BELLANDO RANDONE S, BRUNI C et al.: Bosentan fosters microvascular de-remodelling in systemic sclerosis. Clin Rheumatol 2012; 31: 1723-25.
15. ALIVERNINI S, De SANTIS M, TOLUSSO B et al.: Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol 2009; 60: 426-35.
16. AMANZI L, BRASCHI F, FIORI G et al.: Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 2010; 49: 1374-82.
17. HACHULLA E, CLERSON P, LAUNAY D et al.: Natural history of ischemic digital ulcers in systemic sclerosis: single center retrospective longitudinal study. J Rheumatol 2007; 34: 2423-30.
18. NIHTYANOVA SI, BROUGH GM, BLACK CM, DENTON CP: Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2008; 67: 120-3.
19. WALKER JG, STIRLING J, BEROUKAS D et al.: Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology 2005; 37: 220-5.
20. SHAH AA, WIGLEY FM, HUMMERS LK: Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010; 37; 98-104.
21. LeROY EC, MEDSGER TA Jr.: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
22. VALENTINI G, SILMAN AJ, VEALE D: Assessment of disease activity. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S39-41.
23. MEDSGER TA Jr, BOMBARDIERI S, CZIRJAK L, SCORZA R, Della ROSSA A, BENCIVELLI W: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S42-6.
24. MATUCCI-CERINIC M, BELLANDO-RANDONE S, LEPRI G, BRUNI C, GUIDUCCI S: Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. Ann Rheum Dis 2013; 72: 319-21.
25. Van Den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-47.
26. WALKER UA, TYNDAL A, CZIRJAK L et al.: Clinical risk assessment of organ manifesta-tions in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
27. GUILLEVIN L, HUNSCHE E, DENTON CP et al.: Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. Clin Exp Rheumatol 2013; 31 (Suppl. 76): 71-80.
28. PANOPOULOS ST, BOURNIA VK, SFIKAKIS PP: Is vasculopathy associated with systemic sclerosis more severe in men? J Rheumatol 2013; 40: 46-51.
29. INGEGNOLI F, ARDOINO I, BORACCHI P; EUSTARar co-autThorsS: Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc Res 2013; 89: 122-8.
30. SHAH P, MURRAY AK, MOORE TL, HERRICK AL: Effects of iloprost on microvascular structure assessed by nailfold. J Rheumatol 2011; 38; 2079-80.
31. RICCIERI V, VASILE M, LANNACE N et al.: Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. Rheumatology (Oxford) 2013; 52: 1525-28.
32. KAYSER C, SEKIYAMA JY, PRóSPERO LC, CAMARGO CZ, ANDRADE LE: Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol 2013; 31 (Suppl. 76): 103-8.
33. ENNIS H, HERRICK AL, CASSIDY C, GRIFFITHS CE, RICHARDS HL: A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. Clin Exp Rheumatol 2013; 31 (Suppl. 76): 12-7.